Cambrian Bio - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeCambrian Bio
Cambrian Bio logo

Cambrian Bio

0 followers

About Cambrian Bio

Cambrian Bio is a clinical-stage drug development company focused on creating therapeutics designed to prevent diseases and lengthen healthspan. It emphasizes aging biology and the development of medicines to modify the course of chronic diseases, aiming to modernize healthcare in the 21st century. The company collaborates with scientists and operates across the biomedical innovation ecosystem to bring new medicines from research to clinical testing.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

Mark Nuttall, PhD

Chief Business Officer

Ruth Thieroff-Ekerdt, MD

Chief Medical Officer

James Peyer, PhD

CEO, Founder

Juliette Han, PhD

Chief Financial Officer & Chief Operating Officer

Key Facts

HQ Location

San Francisco, United States

Founded

2019

Employees

11 - 50

Status

Private

Website

https://cambrianbio.com